Skip to main content
≥99.0% HPLC Verified • SEPA Bank & Crypto • Min. Order €220
Neuropeptides & Cognition 3 min read

Melanotan II: Cyclic Lactam Architecture, Melanocortin Receptor Subtypes, and Potency

Compiled & reviewed by SwissLab Analytical Chemistry & QC Team — Chromatography, Mass Spectrometry & Solubility Review Desk
Editorial Standards
Analytical Summary

A structural review of cyclic heptapeptide Melanotan II (Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2). Receptor affinities (MC1R–MC5R), cyclic lactam stability, and analytical standards. Melanotan II is a synthetic cyclic lactam analogue of alpha-melanocyte-stimulating hormone (α-MSH).

Key Research Takeaways
  • Melanotan II is a synthetic cyclic lactam analogue of alpha-melanocyte-stimulating hormone (α-MSH).
  • The internal lactam bridge between Asp and Lys confers exceptional resistance to enzymatic cleavage and proteolytic degradation.
  • Exhibits broad-spectrum affinity across melanocortin receptors: MC1R (eumelanin pigmentation), MC3R/MC4R (metabolism and sexual function), and MC5R (exocrine glands).
  • Substitution of native L-Phe with D-Phe7 is the key structural modification providing super-potent agonism.
  • High chemical stability allows extended storage in lyophilized form at -20°C.
Analytical & Handling Reference Matrix
CAS Registry Number 121062-08-6
Molecular Formula C50H69N15O9
Molecular Mass 1024.18 g/mol
Primary Biological Target Melanocortin Receptors (MC1R, MC3R, MC4R, MC5R)
Analytical Purity Standard ≥99.0% (RP-HPLC, C18, 214/220 nm)
Identity Verification ESI-MS (±0.1 Da) + Karl Fischer Moisture (<3.0%)
Lyophilized Storage -20°C desiccated, protected from UV light (24–36 months)
Reconstituted Storage 2°C–8°C refrigerated (up to 28 days in 0.9% BA BAC water)

1. Chemical Design and the Cyclic Lactam Bridge

Melanotan II (MT-2) is a synthetic cyclic heptapeptide with the sequence Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2. Developed at the University of Arizona, it was designed to overcome the rapid in-vivo degradation of linear α-MSH. By cyclizing the peptide through an amide (lactam) bond between the beta-carboxyl group of Asp4 and the epsilon-amino group of Lys9, the pharmacophore is locked in an active beta-turn conformation that resists serum endopeptidases.

2. Melanocortin Receptor Subtype Affinities

Melanotan II acts as a non-selective melanocortin receptor agonist. Activation of MC1R on cutaneous melanocytes stimulates tyrosinase activity and eumelanin synthesis. Stimulation of central MC4R and MC3R in the hypothalamus influences energy expenditure, appetite regulation, and central erectile signaling cascades via dopamine and oxytocin release in the medial preoptic area.

3. Difference Between Melanotan I (Afamelanotide) and Melanotan II

Melanotan I (Afamelanotide) is a linear 13-amino acid peptide ([Nle4, D-Phe7]-α-MSH) with high selectivity for MC1R. Melanotan II is a truncated, cyclic 7-amino acid analogue with higher lipid solubility, greater central nervous system penetration, and potent activity at MC3R/MC4R in addition to MC1R.

4. Laboratory Preparation and Solubility

Melanotan II is a highly water-soluble white lyophilized powder. It dissolves immediately in Bacteriostatic Water or sterile 0.9% saline at concentrations of 10 mg/mL without requiring acid or organic co-solvents. Reconstituted solutions maintain potency for up to 30 days when refrigerated at 2°C to 8°C.

5. Bench Preparation & Assay Reproducibility for Melanotan II

When designing in-vitro experiments targeting Melanocortin Receptors (MC1R, MC3R, MC4R, MC5R), normalize dosing across replicates by molar concentration (µM or nM) using the published molecular weight (1024.18 g/mol) and batch counterion composition rather than gross powder weight alone. Log lot numbers, diluent pH, and aliquot dates to ensure batch-to-batch reproducibility across longitudinal experiments.

Peer-Reviewed References & Analytical Standards

  1. Al-Obeidi F. et al. (1989). Design of a new class of superpotent cyclic alpha-melanotropins based on quenched dynamic simulations. Journal of the American Chemical Society, 111(9), 3413–3416. [DOI: 10.1021/ja00191a044 ↗]
  2. Dorr R.T. et al. (1996). Evaluation of melanotan-II, a superpotent cyclic melanotropic peptide in a pilot phase-I clinical study. Life Sciences, 58(20), 1777–1784. [PMID: 8637402 ↗]

Referenced Laboratory Research Reagents

Batch-verified SwissLab catalog entries cited in this monograph

All 66 Compounds →
Laboratory Compliance & Handling Protocol

All analytical monographs and chemical data are published strictly for in-vitro laboratory research and scientific reference. Reagents must be handled by qualified personnel wearing appropriate PPE. Not for human or veterinary use.

Related Research Monographs

All monographs (44)

Your Research Cart

0 items selected • Min. order €220

SEPA Bank Transfer & Crypto (BTC, ETH, USDT, USDC, SOL, XMR)
Min €220

Your cart is empty

Browse our catalog of research peptides and reagents (minimum order €220).

Browse Catalog